CORRECTING and REPLACING — BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026 10:30 ET | Source: BridgeBio Pharma, Inc. - Preliminary unaudited…
